Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Published in: Journal of Allergy and Clinical Immunology

Volume 128, Issue 5, pp. 989-995.e8

DOI: 10.1016/j.jaci.2011.07.056